Characterizing the Health-Related Quality of Life Burden of Overactive Bladder Using Disease-Specific Patient-Reported Outcome Measures: A Systematic Literature Review

ConclusionThe HRQoL burden of OAB and response to treatment can be reliably measured by PRO instruments, and the OAB-q is the most commonly used instrument in OAB, particularly in clinical trials of OAB interventions. These data will be useful to provide benchmarks of burden levels for PRO scores obtained among those on contemporary therapies for comparison with outcomes from patients managed with emerging treatments.FundingAstellas Pharma Global Development, Inc.

http://link.springer.com/10.1007/s12325-019-0880-8

Source: Advances in Therapy - February 4, 2019 Category: Drugs & Pharmacology Source Type: research